Consequently, the expression levels of NLRP3 and its downstream proteins were inhibited by the administration of U50488H, which suggested that KOR agonists suppressed the activation of the NLRP3 inflammasome in MI cells. The gene discussed is NLRP3; the disease is myocardial infarction.